Dogwood Therapeutics (NASDAQ:DWTX – Get Free Report) will be posting its quarterly earnings results before the market opens on Thursday, November 7th. Analysts expect Dogwood Therapeutics to post earnings of ($1.33) per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.
Dogwood Therapeutics (NASDAQ:DWTX – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($1.25) EPS for the quarter, beating analysts’ consensus estimates of ($1.75) by $0.50. On average, analysts expect Dogwood Therapeutics to post $-5 EPS for the current fiscal year and $-4 EPS for the next fiscal year.
Dogwood Therapeutics Stock Up 4.1 %
Shares of DWTX opened at $4.62 on Wednesday. Dogwood Therapeutics has a 52-week low of $2.50 and a 52-week high of $26.00.
Dogwood Therapeutics Company Profile
Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company’s lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.
Read More
- Five stocks we like better than Dogwood Therapeutics
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- AMD: The AI Disruptor – Is It Time to Follow Big Tech’s Lead?
- Breakout Stocks: What They Are and How to Identify Them
- Analysts Signal Big Upside: Top 3 Stocks to Watch Right Now
- Investing In Preferred Stock vs. Common Stock
- Bears Misjudged These 3 ETFs: Where Investors Can Find Upside
Receive News & Ratings for Dogwood Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dogwood Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
